Ovid Therapeutics (NasdaqGS:OVID) FY Conference Transcript

Ovid Therapeutics (NasdaqGS:OVID) FY Conference March 04, 2026 09:50 AM ET Company ParticipantsMeg Alexander - President and CEOConference Call ParticipantsRitu Baral - Managing Director and Senior Biotechnology AnalystRitu BaralGood morning. Thanks for joining us for the Ovid presentation here at the 46th annual TD Cowen Healthcare Conference. I'm TD Cowen senior biotech analyst and covering analyst for Ovid, Ritu Baral. Here for the presentation with extended Q&A at the end, is Ovid CEO, Meg Alexander. Me ...